(Q41156152)

English

Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence

scientific article published on August 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence (English)

1 reference

Europe PubMed Central

27 September 2017

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Pyörälä K

1

1 reference

Europe PubMed Central

27 September 2017

Steiner G

2

1 reference

Europe PubMed Central

27 September 2017

language of work or name

0 references

publication date

1 August 1996

1 reference

Europe PubMed Central

27 September 2017

Annals of Medicine

1 reference

Europe PubMed Central

27 September 2017

28

1 reference

Europe PubMed Central

27 September 2017

4

1 reference

Europe PubMed Central

27 September 2017

357-362

1 reference

Europe PubMed Central

27 September 2017

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Long-term prognosis after myocardial infarction in men with diabetes.

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

The value of lowering cholesterol after myocardial infarction

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Cholesterol lowering and mortality: the importance of considering initial level of risk

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Cholesterol reduction yields clinical benefit. A new look at old data

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Retardation and arrest of progression or regression of coronary artery disease: a review

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

The triglyceride issue revisited. Findings from the Helsinki Heart Study.

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Prognostic significance of progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999093

21 January 2018

Identifiers

10.3109/07853899608999093

1 reference

Europe PubMed Central

27 September 2017

release_od2htotbpbdzzph6cfmddgyk64

1 reference

https://api.fatcat.wiki/v0/release/od2htotbpbdzzph6cfmddgyk64

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41156152&oldid=1916320860"